These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30192548)

  • 1. Innovative DNA-Targeted Metallo-prodrug Strategy Combining Histone Deacetylase Inhibition with Oxidative Stress.
    McGivern TJP; Slator C; Kellett A; Marmion CJ
    Mol Pharm; 2018 Nov; 15(11):5058-5071. PubMed ID: 30192548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Endogenous Reactive Oxygen Species (ROS)-Activated Histone Deacetylase Inhibitor Prodrug for Cancer Chemotherapy.
    Bhagat SD; Singh U; Mishra RK; Srivastava A
    ChemMedChem; 2018 Oct; 13(19):2073-2079. PubMed ID: 30070768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
    Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
    Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypyridyl-Based Copper Phenanthrene Complexes: Combining Stability with Enhanced DNA Recognition.
    Fantoni NZ; Molphy Z; O'Carroll S; Menounou G; Mitrikas G; Krokidis MG; Chatgilialoglu C; Colleran J; Banasiak A; Clynes M; Roche S; Kelly S; McKee V; Kellett A
    Chemistry; 2021 Jan; 27(3):971-983. PubMed ID: 32519773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-Mode HDAC Prodrug for Covalent Modification and Subsequent Inhibitor Release.
    Daniel KB; Sullivan ED; Chen Y; Chan JC; Jennings PA; Fierke CA; Cohen SM
    J Med Chem; 2015 Jun; 58(11):4812-21. PubMed ID: 25974739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone-deacetylase-targeted fluorescent ruthenium(II) polypyridyl complexes as potent anticancer agents.
    Ye RR; Ke ZF; Tan CP; He L; Ji LN; Mao ZW
    Chemistry; 2013 Jul; 19(31):10160-9. PubMed ID: 23828334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical-induced DNA damage by cytotoxic square-planar copper(II) complexes incorporating o-phthalate and 1,10-phenanthroline or 2,2'-dipyridyl.
    Kellett A; Howe O; O'Connor M; McCann M; Creaven BS; McClean S; Foltyn-Arfa Kia A; Casey A; Devereux M
    Free Radic Biol Med; 2012 Aug; 53(3):564-76. PubMed ID: 22659117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway.
    Shi XY; Ding W; Li TQ; Zhang YX; Zhao SC
    Med Sci Monit; 2017 Dec; 23():5793-5802. PubMed ID: 29211704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Palladium-Triggered Release of Vorinostat from a Bioorthogonal Precursor.
    Rubio-Ruiz B; Weiss JT; Unciti-Broceta A
    J Med Chem; 2016 Nov; 59(21):9974-9980. PubMed ID: 27786474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of N-(6-mercaptohexyl)-3-(4-pyridyl)-1H-pyrazole-5-carboxamide and its disulfide prodrug as potent histone deacetylase inhibitors with in vitro and in vivo anti-tumor efficacy.
    Wen J; Bao Y; Niu Q; Yang J; Fan Y; Li J; Jing Y; Zhao L; Liu D
    Eur J Med Chem; 2016 Feb; 109():350-9. PubMed ID: 26814680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new class of prophylactic metallo-antibiotic possessing potent anti-cancer and anti-microbial properties.
    Ude Z; Kavanagh K; Twamley B; Pour M; Gathergood N; Kellett A; Marmion CJ
    Dalton Trans; 2019 Jun; 48(24):8578-8593. PubMed ID: 30946409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of histone deacetylase inhibitor and tumor cell-growth inhibition properties of new benzofuranone compounds.
    Blanquart C; François M; Charrier C; Bertrand P; Gregoire M
    Curr Cancer Drug Targets; 2011 Oct; 11(8):919-28. PubMed ID: 21762083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
    Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines.
    Jang YG; Hwang KA; Choi KC
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity.
    Negmeldin AT; Pflum MKH
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3254-3258. PubMed ID: 28648461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A series of camptothecin prodrugs exhibit HDAC inhibition activity.
    Zhu Q; Yu X; Shen Q; Zhang Q; Su M; Zhou Y; Li J; Chen Y; Lu W
    Bioorg Med Chem; 2018 Sep; 26(16):4706-4715. PubMed ID: 30115492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carfilzomib combined with suberanilohydroxamic acid (SAHA) synergistically promotes endoplasmic reticulum stress in non-small cell lung cancer cell lines.
    Hanke NT; Garland LL; Baker AF
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):549-60. PubMed ID: 26385374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Combination of Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and Natural Flavonoid Curcumin Exhibits Anticancer and Antibacterial Activity.
    Altundağ EM; Toprak K; Şanlıtürk G; Güran M; Özbilenler C; Kerküklü NR; Yılmaz AM; Yalçın AS
    Anticancer Agents Med Chem; 2021; 21(10):1301-1308. PubMed ID: 33023457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, DNA binding, cellular DNA lesion and cytotoxicity of a series of new benzimidazole-based Schiff base copper(II) complexes.
    Paul A; Anbu S; Sharma G; Kuznetsov ML; Koch B; Guedes da Silva MF; Pombeiro AJ
    Dalton Trans; 2015 Dec; 44(46):19983-96. PubMed ID: 26523453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
    You BR; Han BR; Park WH
    Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.